Lansoprazole Capsule, Delayed Release
Product Images NDC 70756-806

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 70756-806). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lifestar Pharma Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

F53ca2be A290 4157 Ad95 D24dfe3344f9 01

Chemical structure of the active ingredient Lansoprazole showing its molecular framework including benzene rings, sulfoxide group, and substituted pyridine and benzimidazole moieties.*

FDA Label Image

F53ca2be A290 4157 Ad95 D24dfe3344f9 02

A line graph titled 'Mean Severity of Day Heartburn By Study Day For Evaluable Patients' comparing mean day heartburn severity scores over time. The x-axis represents days from start of treatment, ranging from -5 to 60. The y-axis shows mean severity of day heartburn on a scale from 0 (none) to 3 (severe). Three lines represent Placebo, Lansoprazole 15 mg once daily, and Lansoprazole 30 mg once daily, showing Lansoprazole groups having lower mean severity than Placebo over the treatment period.*

FDA Label Image

F53ca2be A290 4157 Ad95 D24dfe3344f9 03

A line graph showing the mean severity of night heartburn over approximately 60 days from the start of treatment. It compares three groups: placebo, Lansoprazole 15 mg once daily, and Lansoprazole 30 mg once daily. Severity is rated on a scale from 0 (none) to 3 (severe). Both Lansoprazole doses show a rapid decrease and sustained lower severity compared to placebo throughout the study period.*

FDA Label Image

F53ca2be A290 4157 Ad95 D24dfe3344f9 04

Packaging label for Lansoprazole 15 mg delayed-release capsules, USP by Lifestar Pharma LLC. The label states the product contains 30 capsules, with each capsule containing 15 mg of lansoprazole as enteric-coated pellets. It includes storage instructions at 25°C, manufacturer details in India, and a barcode with serialization information.*

FDA Label Image

F53ca2be A290 4157 Ad95 D24dfe3344f9 05

Lansoprazole 30 mg delayed-release capsules, USP label for a 30-capsule bottle by Lifestar Pharma LLC. The label includes dosage strength, NDC number 70756-807-30, manufacturer details, storage instructions, and dispensing cautions. It indicates the capsules contain enteric-coated pellets and emphasizes Rx only status with medication guide advice for pharmacists.*

FDA Label Image

F53ca2be A290 4157 Ad95 D24dfe3344f9 1

Lansoprazole 15 mg delayed release oral capsules by Lifestar Pharma LLC. The image shows a white and blue carton with the brand name Lansoprazole prominently displayed along with the dosage strength. The Lifestar Pharma LLC logo is visible in the top left corner of the package.*

FDA Label Image

F53ca2be A290 4157 Ad95 D24dfe3344f9 2

FDA Label Image

F53ca2be A290 4157 Ad95 D24dfe3344f9 6

Lansoprazole 15 mg delayed-release capsules carton from Lifestar Pharma LLC. The box displays the proprietary and generic name, strength, dosage form, and labeler. The packaging has a predominantly white background with blue and gray elements and the Lifestar Pharma logo in the upper left corner.*

FDA Label Image

F53ca2be A290 4157 Ad95 D24dfe3344f9 7

Lansoprazole 15 mg delayed-release capsules packaging label by Lifestar Pharma LLC. The label includes the brand name Lansoprazole, generic name, dosage form, strength of 15 mg, and the oral route. The Lifestar Pharma LLC logo is displayed on the label, which features a clear layout for prescription use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.